发明名称 Block copolymer having phenylboronic acid group introduced therein, and use thereof
摘要 A block copolymer includes a polyamino acid chain segment and a hydrophilic polymer chain segment. The polyamino acid chain segment includes at least one amino acid residue having a side chain that contains a cationic group and at least one amino acid residue having a side chain that contains a substituted phenylboronic acid group. In the substituted phenylboronic acid group, at least one hydrogen of the phenyl ring is substituted so that the phenylboronic acid group has a pKa of less than 8. Such a block copolymer serves as a carrier that simultaneously imparts stability to a biotechnology-based drug in blood and provides suitable drug-releasing properties of the drug at an affected area.
申请公布号 US9114177(B2) 申请公布日期 2015.08.25
申请号 US201214358816 申请日期 2012.11.19
申请人 THE UNIVERSITY OF TOKYO;NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY;NANOCARRIER CO., LTD. 发明人 Kataoka Kazunori;Ishii Takehiko;Naito Mitsuru;Matsumoto Akira;Kato Yasuki
分类号 A61K31/713;A61K47/48;C08G81/00;C08G69/40;C08G69/42 主分类号 A61K31/713
代理机构 J-Tek Law PLLC 代理人 J-Tek Law PLLC ;Tekanic Jeffrey D.;Wakeman Scott T.
主权项 1. A pharmaceutical composition, comprising a complex of: a block copolymer having a polyamino acid chain segment and a hydrophilic polymer chain segment, and a nucleic acid, wherein the polyamino acid chain segment includes at least one amino acid residue having a side chain that contains a cationic group and at least one amino acid residue having a side chain that contains a substituted phenylboronic acid group, at least one hydrogen atom of the phenyl ring of the substituted phenylboronic acid group has been substituted so that the substituted phenylboronic acid group has a pKa of less than 8, and the nucleic acid is reversibly covalently bound to the substituted phenylboronic acid group.
地址 Tokyo JP